Nanoparticle Formulations in Biomarker Detection
OwnerVuong Trieu, Larn Hwanginventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods of treatment of cancer patients with cytotoxic drugs in particular the use of cytotoxic drugs encapsulated in a diblock copolymer formulation where the composition is stable in protein free media and less stable in protein containing media such as serum, in particular the treatment of ovarian.
Claims21
A method of treating patients with ovarian cancer comprising administering paclitaxel containing micelles and carboplatin to the patient.
A conditionally stable micelle composition containing an active compound wherein the composition is stable in protein-free medium and unstable in a protein containing medium.
21-50. (canceled)
Dependencies are inferred from the claim text.